global health

The World Health Organization (WHO) has recently announced the updated influenza vaccine strains for the 2025-2026 northern hemisphere flu season. This update, which was released on February 28, 2025, is part of WHO's ongoing effort to maintain the efficacy of seasonal influenza vaccines. Each year, the global health body evaluates the evolving epidemiological, virological, and serological data to provide recommendations for the coming flu season. These recommendations reflect the dynamic nature of influenza viruses, particularly their tendency to mutate and evolve.

Breast cancer diagnoses and deaths are projected to surge worldwide by 2050, presenting a major public health challenge, according to new data from the World Health Organization’s cancer agency. The International Agency for Research on Cancer (IARC) has conducted an analysis that suggests breast cancer cases will rise by 38%, and deaths by 68% globally. In the UK alone, the number of new cases is expected to increase by 21%, while deaths will rise by a staggering 42%.

Human Metapneumovirus (HMPV) has emerged as a significant respiratory pathogen, particularly among vulnerable populations. This article provides an overview of HMPV, detailing its symptoms, diagnosis, treatment, and preventive measures amidst a recent surge in cases. Experts clarify that HMPV is not a new threat, but a recognized pathogen that presents challenges due to its flu-like symptoms. Understanding its characteristics and implementing effective public health strategies are crucial to managing its spread and supporting those affected. Stay informed with the latest recommendations on HMPV and respiratory health.